Article
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
Molecular psychiatry - 1 Jun 2004
Sjøholt G, Ebstein R P, Lie R T, Berle J Ø, Mallet J, Deleuze J F, Levinson D F, Laurent C, Mujahed M, Bannoura I, Murad I, Molven A, Steen V M
Abstract excerpt
Manic-depressive (bipolar) illness is a serious psychiatric disorder with a strong genetic predisposition. The disorder is likely to be multifactorial and etiologically complex, and the causes of genetic susceptibility have been difficult to unveil. Lithium therapy is a widely used pharmacological treatment of manic-depressive illness, which both stabilizes the ongoing episodes and prevents relapses. A putative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
